ILMN (Illumina Inc)
Insider Trading Activity
Every open-market purchase and sale reported by ILMN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | Michael C Sullivan | Chief Commercial Officer | A | — | — |
| 2026-08-06 | Keith A. Meister | Director | Sell | — | — |
| 2026-08-03 | Scott M Davies | Chief Legal Officer | Sell | — | — |
| 2026-07-02 | Scott B. Ullem | Director | A | — | — |
| 2026-07-02 | Keith A. Meister | Director | A | — | — |
| 2026-06-25 | Scott M Davies | Chief Legal Officer | Sell | — | — |
| 2026-06-23 | Daniel Skovronsky | Director | A | — | — |
| 2026-06-09 | Patricia Leckman | SVP, Chief People Officer | Sell | — | — |
| 2026-06-04 | Patricia Leckman | SVP, Chief People Officer | Sell | — | — |
| 2026-06-01 | Scott D Ericksen | VP, Chief Accounting Officer | Sell | — | — |
| 2026-06-01 | Scott M Davies | Chief Legal Officer | Sell | — | — |
| 2026-06-01 | Keith A. Meister | Director | MIXED | — | — |
| 2026-05-29 | Keith A. Meister | Director | — | — | — |
| 2026-05-22 | CAROLINE DORSA | Director | MIXED | — | — |
| 2026-05-22 | Scott Gottlieb | Director | A | — | — |
| 2026-05-22 | Keith A. Meister | Director | A | — | — |
| 2026-05-22 | ANNA RICHO | Director | A | — | — |
| 2026-05-22 | PHILIP W SCHILLER | Director | A | — | — |
| 2026-05-22 | Scott B. Ullem | Director | A | — | — |
| 2026-05-22 | SUSAN E SIEGEL | Director | A | — | — |
| 2026-05-22 | DAVID P KING | Director | A | — | — |
| 2026-05-14 | Keith A. Meister | Director | MIXED | — | — |
| 2026-05-11 | Keith A. Meister | Director | MIXED | — | — |
| 2026-05-07 | Christensen Jakob Wedel | SVP, Strategy/Corp Development | MIXED | — | — |
| 2026-04-02 | Keith A. Meister | Director | A | — | — |
| 2026-04-02 | Scott B. Ullem | Director | A | — | — |
| 2026-03-09 | Christensen Jakob Wedel | SVP, Strategy/Corp Development | A | — | — |
| 2026-03-09 | Jacob Thaysen | Chief Executive Officer | A | — | — |
| 2026-03-09 | Kevin Carl Pegels | Chief of Global Operations | A | — | — |
| 2026-03-09 | Patricia Leckman | SVP, Chief People Officer | A | — | — |
| 2026-03-09 | Scott D Ericksen | VP, Chief Accounting Officer | A | — | — |
| 2026-03-09 | Ankur Dhingra | SVP, Chief Financial Officer | A | — | — |
| 2026-03-09 | Scott M Davies | Chief Legal Officer | A | — | — |
| 2026-03-09 | Steven Barnard | SVP, Chief Technology Officer | A | — | — |
| 2026-02-24 | Scott M Davies | Chief Legal Officer | Sell | — | — |
| 2026-02-18 | Patricia Leckman | SVP, Chief People Officer | MIXED | — | — |
| 2026-02-18 | Christensen Jakob Wedel | SVP, Strategy/Corp Development | F | — | — |
| 2026-02-18 | Jacob Thaysen | Chief Executive Officer | F | — | — |
| 2026-02-18 | Scott M Davies | Chief Legal Officer | F | — | — |
| 2026-02-18 | Kevin Carl Pegels | Chief of Global Operations | F | — | — |
| 2026-02-18 | Scott D Ericksen | VP, Chief Accounting Officer | F | — | — |
| 2026-02-18 | Steven Barnard | SVP, Chief Technology Officer | F | — | — |
| 2026-02-17 | Scott D Ericksen | VP, Chief Accounting Officer | MIXED | — | — |
| 2026-02-17 | Patricia Leckman | SVP, Chief People Officer | MIXED | — | — |
| 2026-02-17 | Scott M Davies | Chief Legal Officer | MIXED | — | — |
| 2026-02-17 | Kevin Carl Pegels | Chief of Global Operations | MIXED | — | — |
| 2026-02-17 | Jacob Thaysen | Chief Executive Officer | MIXED | — | — |
| 2026-02-17 | Steven Barnard | SVP, Chief Technology Officer | MIXED | — | — |
| 2026-02-11 | Scott Gottlieb | Director | Buy | — | — |
| 2026-01-05 | Scott B. Ullem | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 2,096,205 | — |
| — | Sr VP and COO | 685,672 | — |
| — | Director | 670,600 | — |
| — | Sr. VP & GM DNA Sequencing | 164,124 | — |
| — | Director | 152,433 | — |
| — | President and CEO | 120,992 | — |
| — | EVP Clinical Genomics | 118,259 | — |
| — | Chief Executive Officer | 109,073 | — |
| — | Director | 95,174 | — |
| — | SVP, Chief Commercial Officer | 89,267 | — |
| — | SVP, Entrepreneurial Devlopmt | 82,762 | — |
| — | Sr. VP, Human Resources | 65,660 | — |
| — | Sr VP & General Manager | 49,837 | — |
| — | Sr VP & General Counsel | 46,553 | — |
| — | SVP, Chief Commercial Officer | 42,614 | — |
| — | SVP, Chief Technology Officer | 41,335 | — |
| — | SVP, Chief Financial Officer | 34,264 | — |
| — | Sr VP & General Manager | 30,858 | — |
| — | Sr VP, Corporate Development | 30,020 | — |
| — | Chief of Global Operations | 29,038 | — |
| — | Sr VP & General Manager | 27,365 | — |
| — | SVP, General Counsel | 26,790 | — |
| — | SVP, Chief Financial Officer | 24,478 | — |
| — | Sr VP, Chief Medical Officer | 22,847 | — |
| — | Director | 22,220 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ILMN quote page; the site-wide leaderboard is on the insider transactions hub.